CN110305193A - 一种抗牙龈卟啉单胞菌多肽及应用 - Google Patents

一种抗牙龈卟啉单胞菌多肽及应用 Download PDF

Info

Publication number
CN110305193A
CN110305193A CN201910649708.2A CN201910649708A CN110305193A CN 110305193 A CN110305193 A CN 110305193A CN 201910649708 A CN201910649708 A CN 201910649708A CN 110305193 A CN110305193 A CN 110305193A
Authority
CN
China
Prior art keywords
polypeptide
porphyromonas gingivalis
arg
leu
resisting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910649708.2A
Other languages
English (en)
Other versions
CN110305193B (zh
Inventor
李钟杰
刘其伟
邓博
高社干
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan University of Science and Technology
Original Assignee
Henan University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan University of Science and Technology filed Critical Henan University of Science and Technology
Priority to CN201910649708.2A priority Critical patent/CN110305193B/zh
Publication of CN110305193A publication Critical patent/CN110305193A/zh
Application granted granted Critical
Publication of CN110305193B publication Critical patent/CN110305193B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

本项发明属于医药应用领域，具体涉及一种抗牙龈卟啉单胞菌多肽及应用。该多肽的氨基酸序列为：Gly‑Leu‑Gln‑Phe‑Pro‑Val‑Gly‑Arg‑Ile‑His‑Arg‑Leu‑Leu‑Arg‑Lys，如SEQ ID NO:1所示。本发明所述的抗牙龈卟啉单胞菌多肽适宜制成抗牙龈卟啉单胞菌感染性疾病药物、漱口水及牙膏添加剂。该多肽对牙龈卟啉单胞菌具有较强的抑制作用，且对人血红细胞毒性极小。

Description

一种抗牙龈卟啉单胞菌多肽及应用
技术领域
本项发明属于医药应用领域，具体涉及一种抗牙龈卟啉单胞菌多肽及应用。
背景技术
牙龈卟啉单胞菌是引起牙周炎的主要病原菌，同时牙龈卟啉单胞菌与心血管疾病等疾病密切相关。有效抑制口腔中的牙龈卟啉单胞菌在维持口腔健康及预防其他相关疾病具有重要意义。目前，临床上抑制抑制牙龈卟啉单胞菌的药物多为抗生素，而这些抗生素多不具有特异性，且会引起一系列的副反应。抗微生物多肽具有作用好副作用低等特征，特异性作用于口腔致病菌牙龈卟啉单胞菌的多肽具有很好的应用前景。
发明内容
本发明旨在提供一种抗牙龈卟啉单胞菌多肽，该多肽能够治疗牙龈卟啉单胞菌相关感染，且无毒副作用。
本发明的第一个目的是提供一种抗牙龈卟啉单胞菌多肽及应用，所述多肽的氨基酸序列为：Gly-Leu-Gln-Phe-Pro-Val-Gly-Arg-Ile-His-Arg-Leu-Leu-Arg-Lys，如序列表SEQ ID NO:1所示，。
本发明的第二个目的是提供上述多肽在制备牙龈卟啉单胞菌感染性疾病药物中的应用。
本发明的第三个目的是提供上述多肽在制备漱口水中的应用。
本发明的第四个目的是提供上述多肽在制备牙膏添加剂中的应用。
与现有技术相比，本发明具有如下有效果：
本发明所述的抗牙龈卟啉单胞菌多肽可抑制牙龈卟啉单胞菌，且对人血红细胞毒性极小，具有开发成抗牙龈卟啉单胞菌药物、牙膏添加剂和漱口水的潜力，可用于防治牙龈卟啉单胞菌引起的牙周疾病。
附图说明
图1为实施例3中抗牙龈卟啉单胞菌多肽抑菌效果图(A：牙龈卟啉单胞菌不加多肽处理；B：牙龈卟啉单胞菌加多肽处理)。
图2为实施例3中培养时间与OD值的关系图。
图3为实施例4中抗牙龈卟啉单胞菌多肽的溶血活性图。
具体实施方式
下面结合附图和具体实施例对本发明进行详细说明，但不应理解为本发明的限制。如无特殊说明，下述实施例中所用的技术手段为本领域技术人员所熟知的常规手段，下述实施例中所用的材料、试剂等，如无特殊说明，均可从商业途径得到。
实施例1
抗牙龈卟啉单胞菌多肽的筛选及获得
本发明提出的抗菌多肽来源于我们所构建的中药黄蛞蝓多肽序列数据库，其氨基酸序列如下：Gly-Leu-Gln-Phe-Pro-Val-Gly-Arg-Ile-His-Arg-Leu-Leu-Arg-Lys，如序列表SEQ ID NO:1所示。根据所示的氨基酸序列，经吉尔生化(上海)有限公司合成得到对应的抗菌多肽，其纯度>95％。
实施例2
抗牙龈卟啉单胞菌多肽的抑菌活性
将多肽配置成为一定浓度储存备用，以生理盐为稀释液，通过二倍稀释法配置系列梯度的多肽溶液。将对数生长期的待测菌液用新鲜的培养基调整为约105-106CFU/mL用于接种，其中牙龈卟啉单胞菌及具核酸杆菌所用培养基为ATCC Medium 2722，正常菌株所用培养基为LB。分别取上述多肽溶液和菌液100μL加入无菌的96孔细胞培养版中，每个多肽浓度3个平行。37℃恒温培养，牙龈卟啉单胞菌厌氧培养48h，常规菌正常培养18-24h,以肉眼无可见细菌生长的最低多肽浓度为该多肽对检测菌的最小抑菌浓度。
抗牙龈卟啉单胞菌多肽的抗菌活性如表1所示，由表1可以看出，该多肽主要对牙龈卟啉单胞菌具有很好的抗菌活性，其最小抑菌浓度为12.5μg/mL。而在100μg/mL的浓度下对金黄色葡萄球菌、大肠杆菌、表皮葡萄球菌、铜绿假单胞菌和白色念珠菌没有抗菌活性。说明该多肽具有很好的细菌选择性。
表1
实施例3
抗牙龈卟啉单胞菌多肽抑菌效果的有效性
将对数生长期的待测菌液用新鲜的培养基ATCC Medium 2722调整为约105-106CFU/mL，加入抗菌多肽，抗菌多肽终浓度为100μg/mL，不加抗菌多肽为对照。37℃恒温培养，牙龈卟啉单胞菌及具核酸杆菌厌氧培养120h，观测细菌生长情况并检测培养体系OD630吸光值。
抗菌多肽的抗菌有效性如图1所示，图中，A：牙龈卟啉单胞菌不加多肽处理；B：牙龈卟啉单胞菌加多肽处理。由图1可以看出，经多肽处理的牙龈卟啉单胞菌(试管B)培养了120h后，培养体系依然为透明的；而未经多肽处理的牙龈卟啉单胞菌(试管A)培养了120h后，培养体系为浑浊的。如图2所示，经多肽处理后的培养体系其OD630吸光值在120h依然为基础吸光值。由此可以说明该多肽对牙龈卟啉单胞菌和具核酸杆菌具有很好的抗菌有效性，有效性最少可维持120h。说明该多肽具有持久或者高效的抑菌作用。
实施例4
抗牙龈卟啉单胞菌多肽的溶血活性
采集健康人新鲜血液抗凝血2mL，1000g离心5min，弃血浆收集红细胞。将收集到的红细胞用生理盐洗涤三遍，按2％(V/V)的比例重悬血细胞。在无菌的96孔细胞培养板中加入100μL上述红细胞重悬液，再分别加入不同浓度的多肽溶液，每个多肽浓度设置3个平行。以0.1％Tritonx-100作为完全溶血的阳性对照，以生理盐组作为不溶血的阴性对照。37℃孵育1h，1000g离心10min。离心后将上清转移到新的无菌96孔细胞培养板中，并利用酶标仪检测570nm处的光吸收值。计算多肽的溶血活性。
抗牙龈卟啉单胞菌及具核酸杆菌多肽溶血活性如图3所示，该多肽在400μg/mL的浓度下表现出较低的溶血活性，说明其毒副作用低。
尽管已描述了本发明的优选实施例，但本领域内的技术人员一旦得知了基本创造性概念，则可对这些实施例作出另外的变更和修改。所以，所附权利要求意欲解释为包括优选实施例以及落入本发明范围的所有变更和修改。
显然，本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样，倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内，则本发明也意图包含这些改动和变型在内。
序列表
<110> 河南科技大学
<120> 一种抗牙龈卟啉单胞菌多肽及其应用
<160> 1
<170> SIPOSequenceListing 1.0
<210> 1
<211> 15
<212> PRT
<213> 人工序列
<400> 1
Gly Leu Gln Phe Pro Val Gly Arg Ile His Arg Leu Leu Arg Lys
1 5 10 15

Claims (4)

1.一种抗牙龈卟啉单胞菌多肽，其特征在于，所述多肽的氨基酸序列为：Gly-Leu-Gln-Phe-Pro-Val-Gly-Arg-Ile-His-Arg-Leu-Leu-Arg-Lys，如SEQ ID NO：1所示。
2.如权利要求1所述抗牙龈卟啉单胞菌多肽在制备用于治疗牙龈卟啉单胞菌感染性疾病药物中的应用。
3.如权利要求1所述抗牙龈卟啉单胞菌多肽在制备漱口水中的应用。
4.如权利要求1所述抗牙龈卟啉单胞菌多肽在制备牙膏添加剂中的应用。
CN201910649708.2A 2019-07-18 2019-07-18 一种抗牙龈卟啉单胞菌多肽及应用 Active CN110305193B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910649708.2A CN110305193B (zh) 2019-07-18 2019-07-18 一种抗牙龈卟啉单胞菌多肽及应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910649708.2A CN110305193B (zh) 2019-07-18 2019-07-18 一种抗牙龈卟啉单胞菌多肽及应用

Publications (2)

Publication Number Publication Date
CN110305193A true CN110305193A (zh) 2019-10-08
CN110305193B CN110305193B (zh) 2021-10-08

Family

ID=68081243

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910649708.2A Active CN110305193B (zh) 2019-07-18 2019-07-18 一种抗牙龈卟啉单胞菌多肽及应用

Country Status (1)

Country Link
CN (1) CN110305193B (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110167955A (zh) * 2016-09-29 2019-08-23 梅哈里医学院 细菌抑制剂
WO2023182185A1 (ja) * 2022-03-25 2023-09-28 メスキュージェナシス株式会社 ジンジパインに対して親和性及び／又は阻害能を有するペプチド及びその使用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1291991A (zh) * 1998-01-22 2001-04-18 株式会社三养吉尼克斯 具有生物学活性的新肽
CN107614004A (zh) * 2015-03-23 2018-01-19 激流生物科学有限公司 抗微生物肽及其使用方法
CN109593114A (zh) * 2019-02-18 2019-04-09 河南科技大学 一种黄蛞蝓抗菌肽、提取方法及其应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1291991A (zh) * 1998-01-22 2001-04-18 株式会社三养吉尼克斯 具有生物学活性的新肽
CN107614004A (zh) * 2015-03-23 2018-01-19 激流生物科学有限公司 抗微生物肽及其使用方法
CN109593114A (zh) * 2019-02-18 2019-04-09 河南科技大学 一种黄蛞蝓抗菌肽、提取方法及其应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PAUL R ET AL.: "Inflammation and Regeneration in the Dentin-pulp Complex: Net Gain or Net Loss?", 《JOURNAL OF ENDODONTICS》 *
李硕果等: "牙龈卟啉单胞菌与食管癌临床病理特征和预后的关系", 《重庆医学》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110167955A (zh) * 2016-09-29 2019-08-23 梅哈里医学院 细菌抑制剂
CN110167955B (zh) * 2016-09-29 2024-04-02 梅哈里医学院 细菌抑制剂
WO2023182185A1 (ja) * 2022-03-25 2023-09-28 メスキュージェナシス株式会社 ジンジパインに対して親和性及び／又は阻害能を有するペプチド及びその使用

Also Published As

Publication number Publication date
CN110305193B (zh) 2021-10-08

Similar Documents

Publication Publication Date Title
Kaplan et al. Extracellular polymeric substance (EPS)-degrading enzymes reduce staphylococcal surface attachment and biocide resistance on pig skin in vivo
Estevinho et al. Antifungal effect of lavender honey against Candida albicans, Candida krusei and Cryptococcus neoformans
Kumarasamy et al. Screening seeds of Scottish plants for antibacterial activity
Arunachalam et al. Studies on bioprospecting of endophytic bacteria from the medicinal plant of Andrographis paniculata for their antimicrobial activity and antibiotic susceptibility pattern
Singariya et al. Comparative Microcidal Activity of Withania somnifera and Cenchrus setigerus against the Pathogenic Micro-organisms
CN110305193A (zh) 一种抗牙龈卟啉单胞菌多肽及应用
CN104177485B (zh) 一种扬子鳄抗菌肽Alligatorin6及其应用
Halawani et al. Shaoka and Sidr honeys surpass in their antibacterial activity local and imported honeys available in Saudi markets against pathogenic and food spoilage bacteria
CN107188944A (zh) 海蚯蚓抗菌肽nz17074衍生肽n6及其应用
CN104163861B (zh) 一种爬行动物抗菌肽Alligatorin5及其应用
Olofin et al. Assessment of the antimicrobial properties of fractions obtained from bryophytes
Gharieb et al. Efficacy of pyocyanin produced by Pseudomonas aeruginosa as a topical treatment of infected skin of rabbits
Dhinakaran et al. Antimicrobial potential of the marine sponge Sigmadocia pumila from the south eastern region of India
Oyagbemi et al. The effect of Cnidoscolus aconitifolius on multi-drug resistant micro-organisms
Farouk et al. Inducible antimicrobial compounds (halal) production in Honey bee larvae (Apis mellifera) from Rumaida, Taif by injecting of various dead microorganisms extracts
CN110272472A (zh) 一种抗牙龈卟啉单胞菌及具核酸杆菌多肽及应用
Rahman et al. Antibacterial efficacy of raw and commercially available honey
CN110305194A (zh) 一种抗菌多肽及应用
CN110317247A (zh) 一种抗口腔致病菌多肽及应用
CN109602894A (zh) 一种天蚕素衍生肽的应用
Effah-Yeboah et al. In-vitro antimicrobial activity of the combined effect of Kalanchoe crenata and Vernonia amygdalina on Salmonella Species
Padilla et al. Quantifying Production of Quorum Sensing Regulated Pigments in Pseudomonas aeruginosa BIOTECH 1335.
Tuan Isolation and evaluation of antimicrobial activity of endophytic actinobacteria on May Chang tree (Litsea cubeba) against pathogenic bacteria causing diseases on common carp and tilapia
Shalini et al. EXPLORATION OF IN-VITRO ANTI-FUNGAL POTENTIAL OF SIDDHA FORMULATION INDIRATHI THRAVAGAM AGAINST CANDIDA ALBICANS USING DISC DIFFUSION ASSAY
CN107266547A (zh) 海蚯蚓抗菌肽nz17074衍生肽n2及其应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Gao Shegan

Inventor after: Li Zhongjie

Inventor after: Liu Qiwei

Inventor before: Li Zhongjie

Inventor before: Liu Qiwei

Inventor before: Deng Bo

Inventor before: Gao Shegan

CB03 Change of inventor or designer information
GR01 Patent grant
GR01 Patent grant